Vall d'Hebron presents positive results from two studies in transfusion-dependent thalassaemia and severe bone marrow aplasia at the EBMT Annual Meeting on haematopoietic stem cell transplantation.
Coincidiendo con la semana mundial de las Inmunodeficiencias Primarias, Vall d'Hebron, el Banco de Sangre y Tejidos, y la BCN PID Foundation celebran una jornada para compartir avances en el tratamien...
Los hallazgos indican la activación del inflamasoma NLRP1 en las células inmunitarias de pacientes durante la enfermedad renal y tras el trasplante de riñón
The goal of researchers is to be able to limit the time that transplant patients are under- or over-exposed to the drug to minimize the risks of organ rejection and treatment toxicity.
For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of rejection, both of which may carry complicatio...